Search Within

CTCR Scholars

Formats
  1. Meeting Abstract (877)
  2. Journal Article (576)
  3. Review (73)
  4. Research Letter (39)
  5. Editorial (30)
  6. Correspondence (25)
  7. Miscellaneous (19)
  8. Book Section (11)
  9. Guidelines (7)
  10. Conference Paper (4)
Groups
  1. Department of Medicine (1431)
  2. Hematologic Malignancies, Division of (1088)
  3. MSK Grad Students (1031)
  4. Master of Science in Clinical and Translational Cancer Research (996)
  5. Center for Hematologic Malignancies (990)
  6. Survivorship Research (931)

More Groups

People
  1. Sergio Giralt (557)
  2. Miguel-Angel Perales (413)
  3. Michael Scordo (389)
  4. Gunjan Shah (345)
  5. Sean Devlin (334)
  6. Parastoo Dahi (305)

More People

Years
  1. 2025 (117)
  2. 2024 (254)
  3. 2023 (261)
  4. 2022 (230)
  5. 2021 (166)
  6. 2020 (211)

More Years

Publications
  1. Blood (318)
  2. Biology of Blood and Marrow Transplantation (187)
  3. Journal of Clinical Oncology (144)
  4. Annals of Surgical Oncology (87)
  5. Bone Marrow Transplantation (65)
  6. Transplantation and Cellular Therapy (56)

More Publications

Publishers
  1. American Society of Hematology (373)
  2. Elsevier Inc. (343)
  3. American Society of Clinical Oncology (160)
  4. Nature Publishing Group (137)
  5. Springer (107)
  6. American Association for Cancer Research (67)

More Publishers

Results (1661)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma
    Meeting Abstract

    Dahi, P. B.; Geyer, A.; Kenny, S.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Lahoud, O. B.; Matasar, M. J.; Moskowitz, C. H.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Interim analysis of the 2nd chance protocol: A multicenter trial of daratumumab, carfilzomib, lenalidomide, & dexamethasone for relapsed/refractory myeloma with salvage autologous hematopoietic cell transplantation
    Meeting Abstract

    Shah, G. L.; Bal, S.; Rodriguez, C.; Chhabra, S.; Bayer, R. L.; Costa, L. J.; Lambird, J.; Ferrer, C.; Parascondola, A.; Marcello, L.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Allogeneic stem cell transplantation improves survival in North American adult T-cell leukemia and lymphoma (NA-ATLL) with CNS involvement with minimal graft versus host disease (GVHD)
    Meeting Abstract

    Patel, R.; Shah, N.; Thakkar, A.; Rahman, S.; Acuna-Villaorduna, A.; Shah, U. A.; Herrera, D. A.; Slasky, S.; Gritsman, K.; Goldfinger, M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Evaluation of potential predictors of central nervous system (CNS) involvement in North American adult T-cell leukemia lymphoma (ATLL) and their survival pattern
    Meeting Abstract

    Patel, R.; Shah, N.; Thakkar, A.; Rahman, S.; Acuna-Villaorduna, A.; Shah, U. A.; Herrera, D. A.; Slasky, S.; Gritsman, K.; Goldfinger, M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy
    Meeting Abstract

    Hubbeling, H.; Silverman, E.; Wijetunga, N. A.; Palomba, M. L.; Tomas, A. A.; Shouval, R.; Batlevi, C. W.; Dahi, P. B.; Giralt, S. A.; Lin, R. J.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • A multi-center collaborative study of outcomes of TP53- mutated MDS/AML patients following allogeneic HCT
    Meeting Abstract

    Byrne, M.; Kurian, T.; Patel, D.; Tamari, R.; Hong, S.; Abdelhakim, H.; Klein, V.; Rojas, P.; Madhavan, R.; Kent, A; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Double unit cord blood transplantation compares favorably to T-cell depleted matched adult donor transplantation for the treatment of acute leukemia due to a robust protection against relapse
    Meeting Abstract

    Politikos, I.; Flynn, J.; Devlin, S. M.; Fingrut, W.; Maloy, M. A.; Naputo, K.; Chinapen, S.; Rodriguez, N. T.; Quach, S.; Dominguez, Y.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Phase II trial of eprenetapopt (APR-246) in combination with azacitidine (AZA) as maintenance therapy for TP53 mutated acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) following allogeneic hematopoietic cell transplantation (HCT)
    Meeting Abstract

    Mishra, A.; Tamari, R.; DeZern, A. E.; Byrne, M.; Gooptu, M.; Bin, C.; Deeg, J.; Gallacher, P.; Wennborg, A.; Kaylor Hickman, D.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Noninvasive genomic characterization of patients with nonsclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease identified a novel gene signature in responders to ruxolitinib cream
    Meeting Abstract

    Markova, A.; Whitaker, J. W.; Ai, R.; Pan, A.; Dusza, S.; Lacouture, M. E.; Chowdhury, A.; Perales, M. A.; Prockop, S. E.; Ponce, D. M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
    Journal Article

    Łuksza, M.; Sethna, Z. M.; Rojas, L. A.; Lihm, J.; Bravi, B.; Elhanati, Y.; Soares, K.; Amisaki, M.; Dobrin, A.; Hoyos, D.; more...
    Nature (2022)

    Fulltext@MSK | Save